For the Media
Dr. Sunil Hingorani is member of Fred Hutch's Clinical Research Division. He leads Fred Hutch’s pancreatic cancer research program and is responsible for some of the most recent and significant breakthroughs in pancreatic cancer research. His work is giving new hope to a disease that is almost uniformly a death sentence by the time it is detected.
Overview of Sunil Hingorani's Research Focus
Dr. Hingorani’s laboratory investigates the molecular and cellular mechanisms that drive the pathogenesis of pancreatic ductal adenocarcinoma (PDA) or, more commonly, pancreas cancer. His work began with a landmark development of a mouse model that faithfully mimics human pancreatic cancer and the discovery that pancreatic tumors surround themselves in dense tissue and isolate themselves from the body’s blood supply – a process that makes them resistant to conventional forms of chemotherapy
Sunil Hingorani's Featured Researcher Profile
Dr. Hingorani's work has yielded some of the most significant advances in decades related to early detection and treatment of pancreas cancer, a disease that is almost uniformly a death sentence by the time it is detected.
Sunil Hingorani- Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.